Exact Sciences Corporation (EXAS)
Company Info
| ISIN | US30063P1057 |
|---|---|
| CUSIP | 30063P105 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Highlights
| Market Cap | $11.07B |
|---|---|
| EPS | -$1.13 |
| PEG Ratio | -1.07 |
| Revenue (TTM) | $2.50B |
| Gross Profit (TTM) | $1.51B |
| EBITDA (TTM) | -$102.23M |
| Year Range | $56.05 - $100.77 |
| Target Price | $90.66 |
| Short % | 3.52% |
| Short Ratio | 3.00 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: EXAS vs. ACHC, EXAS vs. IDXX, EXAS vs. XLV, EXAS vs. XDWT.L, EXAS vs. VOO, EXAS vs. SPY, EXAS vs. AAPL, EXAS vs. BAH
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Exact Sciences Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Exact Sciences Corporation had a return of -15.64% year-to-date (YTD) and -7.46% in the last 12 months. Over the past 10 years, Exact Sciences Corporation had an annualized return of 17.37%, outperforming the S&P 500 benchmark which had an annualized return of 10.42%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -15.64% | 5.05% |
| 1 month | 0.50% | -4.27% |
| 6 months | -2.55% | 18.82% |
| 1 year | -7.46% | 21.22% |
| 5 years (annualized) | -8.10% | 11.38% |
| 10 years (annualized) | 17.37% | 10.42% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -11.60% | -12.03% | 20.04% | |||||||||
| 2023 | -18.47% | -9.72% | 3.91% | 15.59% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Exact Sciences Corporation(EXAS)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Exact Sciences Corporation (EXAS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Exact Sciences Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Exact Sciences Corporation was 98.01%, occurring on Nov 24, 2008. Recovery took 1440 trading sessions.
The current Exact Sciences Corporation drawdown is 59.74%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.01% | Sep 11, 2003 | 1312 | Nov 24, 2008 | 1440 | Aug 18, 2014 | 2752 |
| -84.15% | Jun 25, 2015 | 172 | Mar 1, 2016 | 294 | May 1, 2017 | 466 |
| -80.42% | Feb 16, 2021 | 421 | Oct 14, 2022 | — | — | — |
| -69.06% | Sep 6, 2019 | 134 | Mar 18, 2020 | 155 | Oct 27, 2020 | 289 |
| -64.67% | Feb 2, 2001 | 46 | Apr 9, 2001 | 61 | Jul 6, 2001 | 107 |
Volatility
Volatility Chart
The current Exact Sciences Corporation volatility is 14.48%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |